Reactions of Hypochlorous Acid with Tyrosine and Peptidyl-tyrosyl Residues Give Dichlorinated and Aldehydic Products in Addition to 3-chlorotyrosine
Overview
Affiliations
The toxicity of hypochlorous acid (HOCl) generated from activated neutrophils has been associated with several pathological processes such as atherosclerosis. Formation of 3-chlorotyrosine (Cl-Tyr) has been used as a marker for assessing the involvement of HOCl in such processes. In this study, we aimed to investigate the formation of Cl-Tyr from reaction of HOCl with tyrosine (both free and peptide-bound) and the fate of Cl-Tyr under such conditions. Tyrosine, N-acetyltyrosine, bovine serum albumin, and human low density lipoproteins were incubated with a range of reagent hypochlorite concentrations for varying periods in 10 mM phosphate buffer (pH 7.4) at 22 degrees C. The reaction products, and several biological samples, were hydrolyzed (in the case of proteins), isolated, and purified by high pressure liquid chromatography and characterized or quantitated by mass spectrometry and NMR. A significant amount of 3,5-dichlorotyrosine (diCl-Tyr) was obtained from the bovine serum albumin, low density lipoprotein, and some biological samples, in addition to Cl-Tyr, indicating that Cl-Tyr competes effectively for HOCl even when tyrosine is present in great excess. Cl-Tyr and diCl-Tyr were also formed from free tyrosine but then reacted further with HOCl. This finding differs from a claim in the literature that Cl-Tyr was not formed in such a system. The further reaction products of Cl-Tyr and diCl-Tyr with HOCl were elucidated as their corresponding mono- and dichlorinated 4-hydroxyphenylacetaldehydes. These results indicate the importance of assessing other products of HOCl action in addition to Cl-Tyr.
Leveraging Chlorination-Based Mechanism for Resolving Subcellular Hypochlorous Acid.
Tang F, Tucker L, Nadiveedhi M, Hladun C, Morse J, Ali M bioRxiv. 2024; .
PMID: 39229205 PMC: 11370599. DOI: 10.1101/2024.08.22.609247.
Cartwright I, Zhou L, Koch S, Welch N, Zakharov D, Callahan R JCI Insight. 2024; 9(14).
PMID: 39133648 PMC: 11383587. DOI: 10.1172/jci.insight.178525.
Sultana S, Christeson S, Basiouny M, Rioux J, Veress L, Logue B J Chromatogr B Analyt Technol Biomed Life Sci. 2024; 1235:124042.
PMID: 38354459 PMC: 10939755. DOI: 10.1016/j.jchromb.2024.124042.
Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification.
Cadenas-Garrido P, Schonvandt-Alarcos A, Herrera-Quintana L, Vazquez-Lorente H, Santamaria-Quiles A, Ruiz de Francisco J Antioxidants (Basel). 2024; 13(1).
PMID: 38275652 PMC: 10812581. DOI: 10.3390/antiox13010127.
Discrete interplay of gut microbiota L-tryptophan metabolites in host biology and disease.
Ranhotra H Mol Cell Biochem. 2023; 479(9):2273-2290.
PMID: 37861881 DOI: 10.1007/s11010-023-04867-0.